KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Acquisitions (2020 - 2025)

Historic Acquisitions for GoodRx Holdings (GDRX) over the last 4 years, with Q1 2025 value amounting to $30.0 million.

  • GoodRx Holdings' Acquisitions changed N/A to $30.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year change of. This contributed to the annual value of $156.9 million for FY2022, which is 1182.38% up from last year.
  • Per GoodRx Holdings' latest filing, its Acquisitions stood at $30.0 million for Q1 2025.
  • In the past 5 years, GoodRx Holdings' Acquisitions ranged from a high of $149.9 million in Q2 2022 and a low of $7.0 million during Q1 2022
  • Over the past 3 years, GoodRx Holdings' median Acquisitions value was $30.0 million (recorded in 2025), while the average stood at $65.4 million.
  • Per our database at Business Quant, GoodRx Holdings' Acquisitions crashed by 7393.94% in 2021 and then soared by 1920.73% in 2022.
  • GoodRx Holdings' Acquisitions (Quarter) stood at $14.5 million in 2021, then soared by 930.79% to $149.9 million in 2022, then plummeted by 79.98% to $30.0 million in 2025.
  • Its Acquisitions was $30.0 million in Q1 2025, compared to $149.9 million in Q2 2022 and $7.0 million in Q1 2022.